Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
BJU Int
; 100(6): 1225-8, 2007 Dec.
Article
em En
| MEDLINE
| ID: mdl-17979921
ABSTRACT
In this review we analyse the current status of perioperative systemic chemotherapy in the treatment of transitional cell carcinoma (TCC) of the bladder; instead of summarizing each neoadjuvant or adjuvant clinical trial we focus on the advantages and disadvantages of both strategies on the basis of theoretical considerations, and outline a rationale for a better design of future studies to confirm the efficacy of perioperative chemotherapy in TCC.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Bexiga Urinária
/
Carcinoma de Células de Transição
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Cistectomia
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article